Иммунологические аспекты повторных неудач имплантации в программе экстракорпорального оплодотворения

1. Coughlan C., Ledger W., Wang Q., Liu F., Demirol A., Gurgan T. et al. Recurrent implantation failure: definition and management. Reprod. Biomed. Online. 2014; 28(1): 14-38.

2. Simon A., Laufer N. Repeated implantation failure: clinical approach. Fertil. Steril. 2012; 97(5): 1039-43.

3. Makrigiannakis A., BenKhalifa M., Vrekoussis T., Mahjub S., Kalantaridou S.N., Gurgan T. repeated implantation failure: a new potential treatment option. Eur. J. Clin. Invest. 2011; 45(4): 380-4.

4. Blois S., Klapp B.F., Barrientos G. Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. Reprod. Immunol. 2011; 88(2): 86-92.

5. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin. Reprod. Med. 2007; 25(6): 445-53.

6. Stephenson M.D., Fluker M.R. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo controlled Canadian trial. Fertil. Steril. 2000; 74(6): 1108-13.

7. Makrigiannakis A., Zoumakis E., Kalantaridou S., Coutifaris C., Margioris A.N., Coukos G. et al. Corticotropin-releasing hormonepromotes blastocyst implantation and early maternal tolerance. Nat. Immunol. 2001; 2(11): 1018-24.

8. Trowsdale J., Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin. Immunol. 2008; 20(6):317-20.

9. Nowak I., Malinowski A., Tchórzewski H., Barcz E., Wilczynski J. R., Grybos M. et al. Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion. J. Appl. Genet. 2009; 50(4): 391-8.

10. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 2001; 22(11): 633-40.

11. Moffett A., Regan L., Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004; 329(7477): 1283-5.

12. Bulmer J.N., Lash G.E. Human uterine natural killer cells: a reappraisal. Mol. Immunol. 2005; 42(4): 511-21.

13. Matteo M.G., Greco P., Rosenberg P., Mestice A., Baldini D., Falagario T. et al. Normal percentage of CD56bright natural killer cells young patients with a history of repeated unexplained implantation failure after in vitro fertilization cycles. Fertil. Steril. 2007; 88(4): 990-3.

14. Fukui A., Fujii S., Yamaguchi E., Kimura H., Sato S., Saito Y. Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am. J. Reprod. Immunol. 1999; 41(6): 413-22.

15. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod. 2000; 15(3): 713-8.

16. Wira C.R., Grant-Tschudy K.S., Crane-Godreau M.A. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am. J. Reprod. Immunol. 2005; 53(2): 65-76.

17. Dey S.K., Lim H., Das S.K., Reese J., Paria B.C., Daikoku T., Wang H. Molecular cues to implantation. Endocr. Rev. 2004; 25(3): 341-73.

18. Kalu E., Bhaskaran S., Thum M.Y., Vishwanatha R., Croucher C., Sherriff E. et al. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. Am. J. Reprod. Immunol. 2008; 59(3): 206-11.

19. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010; 63(6): 601-10.

20. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004; 5(3): 266-71.

21. Arruvito L., Sanz M., Banham A.H., Fainboim L. Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007; 178(4): 2572-8.

22. Jasper M.J., Tremellen K.P., Robertson S.A. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod. 2006; 12(5):301-8.

23. Lu Y., Zhang F., Zhang Y., Zeng B., Hu L., Liao A. Quantitative reduction of peripheral CD4+ CD25+ FOXP3+ regulatory T cells in reproductive failure after artificial insemination by donor sperm. Am. J. Reprod. Immunol. 2013; 69(2): 188-93.

24. Lashley L.E., van der Keur C., van Beelen E., Schaap R., van der Westerlaken L.A., Scherjon S.A., Claas F.H. Stronger T – cell alloreactivity and diminished suppressive capacity of peripheral regulatory T cells in infertile women undergoing in vitro fertilization. Am. J. Reprod. Immunol. 2015; 74(3): 268-78.

25. Hunt J.S., Andrews G.K., Wood G.W. Normal trophoblasts resist induction of class I HLA. J. Immunol. 1987; 138(8): 2481-7.

26. Bashirova A.A., Martin M.P., McVicar D.W., Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 2006; 7: 277-300.

27. Hiby S.E., Regan L., Lo W., Farrell L., Carrington M., Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 2008; 23(4): 972-6.

28. Varla-Leftherioti M., Keramitsoglou T., Spyropoulou-Vlachou M., Papadimitropoulos M., Kontopoulou-Antonopoulou V., Tsekoura C. et al. 14th International HLA and Immunogenetics Workshop: report from the reproductive immunology component. Tissue Antigens. 2007; Suppl. 1: 297-303.

29. Tanaka T., Umesaki N., Nishio J., Maeda K., Kawamura T., Araki N. et al. Neonatal thrombocytopenia induced by maternal anti-HLA antibodies: a potential side effect of allogenic leukocyte immunization for unexplained recurrent aborters. J. Reprod. Immunol. 2000; 46: 51-7.

30. Coulam C.B., Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births. J. Reprod. Immunol. 2012; 67(4): 296-304.

31. Stephenson M.D., Kutteh W.H., Purkiss S., Librach C., Schultz P., Houlihan E. et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage:a multicentered randomized placebocontrolled trial. Hum. Reprod. 2010; 25(9): 2203-9.

32. Shreeve N., Sadek K. Intralipid therapy for recurrent implantation failure: new hope or false dawn. J. Reprod. Immunol. 2012; 93: 38-40.

33. Barash A., Dekel N., Fieldust S., Segal I., Schechtman E., Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil. Steril. 2003; 79(6): 1317-22.

34. Karimzadeh M.A., Ayazi Rozbahani M., Tabibnejad N. Endometrial local injury improves the pregnancy rate among reccurent implantation failure patients undergoing in vitro fertilization/intracytoplasmic sperm injection: a randomised clinical trial. Aust. N. Z. J. Obstet. Gynecol. 2009; 49(6): 677-80.

35. Zhou L., Li R., Wang R., Huang H.X., Zhong K. Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates. Fertil. Steril. 2008; 89(5): 1166-76.

36. Raziel A., Schachter M., Strassburger D., Bern O., Ron-El R., Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertil. Steril. 2007; 87(1): 198-201.

37. Narvekar S.A., Gupta N., Shetty N., Kottur A., Srinivas M., Rao K.A. Does local endometrial injury in the nontransfer cycle improve the IVF-ET outcome in the subsequent cycle in patients with previous unsuccessful IVF? A randomized con-trolled pilot study. J. Hum. Reprod. Sci. 2010; 3(1): 15-9.

38. Shohayeb A., El-Khayat W. Does a single endometrial biopsy regimen (S-EBR) improve ICSI outcome in patients with repeated implantation failure? A randomised controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012; 164(2): 176-9.

39. Ledee N., Munaut C., Aubert J., Serazin V., Rahmati M., Chaouat G., Sandra O., Foidart J.M. Specific and extensive endometrial deregulation is present before conception in IVF/ICSI repeated implantation failures (IF) or recurrent miscarriages. J. Pathol. 2011; 225(4): 554-64.

40. Gleicher N., Vidali A., Barad D.H. Successful treatment of unresponsive thin endometrium. Fertil. Steril. 2011; 95(6): 2123. e13-7.

41. Würfel W., Santjohanser C., Hirv K., Bühl M., Meri O., Laubert I. et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Hum. Reprod. 2010; 25(8):2151-2.

42. Schlahsa L., Jaimes Y., Blasczyk R., Figueiredo C. Granulocytecolony- stimulatory factor: a strong inhibitor of natural killer cell function. Transfusion. 2011; 51(2): 293-305.

43. Cavalcante M.B., Costa Fda S., Barini R., Araujo Júnior E. Granulocyte colony-stimulating factor and reproductive medicine: a review. Iran. J. Reprod. Med. 2015; 13(4): 195-202.

44. Boomsma C.M., Kavelaars A., Eijkemans M.J., Lentjes E.G., Fauser B.C., Heijnen C.J., Macklon N.S. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum. Reprod. 2012; 24(6): 1427-35.

45. Nakayama T., Fujiwara H., Maeda M., Inoue T., Yoshioka S., Mori T., Fujii S. Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: HCG enhances the effects of PBMC. Hum. Reprod. 2015; 17(1): 207-12.

46. Yoshioka S., Fujiwara H., Nakayama T., Kosaka K., Mori T., Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum. Reprod. 2006; 21(12): 3290-4.

47. Okitsu O., Kiyokawa M., Oda T., Miyake K., Sato Y., Fujiwara H. Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J. Reprod. Immunol. 2011; 92: 82-7.

48. Fujiwara H., Sato Y., Ideta A., Aoyagi Y., Araki Y., Imakawa K. Immune regulation of human embryo implantation by circulating blood cells. In: Yamada S., ed. The human embryo. Croatia: InTech; 2012: 61-72.

49. Imakawa K., Bai R., Fujiwara H., Kusama K. Conceptus implantation and placentation: molecules related to epithelial-mesenchymal transition, lymphocyte homing, endogenous retroviruses, and exosomes. Reprod. Med. Biol. 2015; 14: 1-11.

50. Schumacher A., Heinze K., Witte J., Poloski E., Linzke N., Woidacki K., Zenclussen A.C. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J. Immunol. 2013; 190(6): 2650-8.

51. Kosaka K., Fujiwara H., Tatsumi K., Yoshioka S., Higuchi T., Sato Y. et al. Human peripheral blood mononuclear cells enhance cell-cell interaction between human endometrial epithelial cells and BeWo-cell spheroids. Hum. Reprod. 2003; 18: 19-25.

52. Li R., Hao G. Local injury to the endometrium: its effect on implantation. Curr. Opin. Obstet. Gynecol. 2009; 21(3): 236-9.

53. Makrigiannakis A., Margioris A.N., Le Goascogne C., Zoumakis E., Nikas G., Stournaras C. et al. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 1995; 57(20): 1869-75.

54. Mor G., Romero R., Aldo P.B., Abrahams V.M. Is the trophoblast an immune regulator? The role of Toll-like receptors during pregnancy. Crit. Rev. Immunol. 2005; 25(5): 375-88.

55. Gnainsky Y., Granot I., Aldo P.B., Barash A., Or Y., Schechtman E. et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil. Steril. 2010; 94(6): 2030-6.

56. Makrigiannakis A., Margioris A.N., Chatzaki E., Zoumakis E., Chrousos G.P., Gravanis A. The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol. Hum. Reprod. 1999; 5(9): 789-96.

Поступила 26.08.2016

Принята в печать 02.09.2016